The use of Artificial Intelligence in healthcare is significantly increasing, with promising new developments that are transforming healthcare. AI has enormous potential to enhance patient care and facilitate health research, but there are also challenges and risks ahead.

Join us on 29 November from for an online discussion on the future of healthcare and the integration of AI in clinical practice and health research. At the occasion of the BioMed Alliance General Assembly we are organising a public policy session during which a series of interesting speakers will share their experience and knowledge on the use of AI & the regulatory framework that intends to facilitate the development and use of AI technologies, while mitigating risks. There will also be time for questions and reflection on what the future will look like, and how we can ensure that clinicians, healthcare professionals and patients are part of the transition.

Speakers:

• Dr. Angela Spatharou (EMEA Lead for Healthcare & Life Sciences, IBM, and EIT Health Supervisory Board member)
• Dr. Gerard R. Dawson (CEO & CSO P1vital LTD and ECNP)
• Salvatore Scalzo (Policy and Legal Officer AI Policy, DG CNECT, European Commission)
• Prof. Frank Rademakers (Emeritus Professor Cardiology KU Leuven and CORE-MD

The session is open to everyone interested upon registration, the dial-in details will be sent to attendees.